ESR1 and breast carcinoma: TFF3 expression is elevated and often associated with prognosis in gastric [8], colorectal [9], hepatocellular [10], thyroid [11], lung [12], pancreatic [13], prostate [14], cervical [15], endometrial [16], and ER+ mammary carcinomas [17–21].